when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
drugs
VIGABATRIN

drug

VIGABATRIN

Marketedupdated 3mo ago

by Novadoz Pharmaceuticals LLC

Approved

community read0 votes

🐶 often sniffed alongside

top 7

tagApproval388 co-mentions · 194 sources
drugSABRIL239 co-mentions · 194 sources
drugVIGADRONE206 co-mentions · 194 sources
drugVigafyde199 co-mentions · 194 sources
tagSmall Molecule194 co-mentions · 194 sources
companyAurobindo Pharma Ltd9 co-mentions · 9 sources
companyZydus Lifesciences Ltd7 co-mentions · 7 sources

all catalysts(100)

approval · 100

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

SABRIL (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

VIGADRONE (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

SABRIL (VIGABATRIN) — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval

view all 100 catalysts →

Trials studying VIGABATRIN

phase3A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasmsterminatedn=2

Patent cliff

source: FDA Orange Book

first barrier falls

Aug 16, 2039

~13.0 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (3)

Jun 8, 2043formulationUS 12576054
Oct 17, 2042formulationUS 12290499
Aug 16, 2039formulationUS 12016857

News(0)

no news has mentioned this drug yet

brand

VIGABATRIN

generic

VIGABATRIN

indication

Complex Partial Seizure

phase

marketed

Data sources

openFDA · ClinicalTrials.gov

last refreshed 2m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?